A Quantitative Systems Pharmacology Model of T Cell Engager Applied to Solid Tumor

Cancer immunotherapy has recently drawn remarkable attention as promising results in the clinic have shown its ability to improve the overall survival, and T cells are considered to be one of the primary effectors for cancer immunotherapy. Enhanced and restored T cell tumoricidal activity has shown...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Huilin, Wang, Hanwen, Sove, Richard J., Jafarnejad, Mohammad, Tsai, Chia-Hung, Wang, Jun, Giragossian, Craig, Popel, Aleksander S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7293198/
https://www.ncbi.nlm.nih.gov/pubmed/32533270
http://dx.doi.org/10.1208/s12248-020-00450-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7293198/
https://www.ncbi.nlm.nih.gov/pubmed/32533270
http://dx.doi.org/10.1208/s12248-020-00450-3

Ejemplares similares